Key financial ranges
Market cap · USD equivalent
P/E ratio
Annual revenue · USD equivalent
Revenue growth
Valuation & profitability
Price / sales
Annual net income · USD equivalent
Net profit margin
Cash & debt
Cash · USD equivalent
Total debt · USD equivalent
Net cash · USD equivalent
Debt / revenue
| Company | Market cap | P/E | Revenue | Rev. growth | Net income | Cash | Debt | AI value |
|---|---|---|---|---|---|---|---|---|
| CAMPCamp4 Therapeutics Corp | $281.76M | — | $3.5M | +436.5% | -$80.4M | $86.4M | $2.37M | AI pending |
| AXINAxiom Intelligence Acquisition Corp 1 | $281.66M | 35.4× | — | — | — | $289.54K | — | AI pending |
| ANIKAnika Therapeutics, Inc. | $281.31M | — | $112.82M | -5.9% | -$10.88M | $38.41M | $25.25M | AI pending |
| XCBEX3 Acquisition Corp. Ltd. | $281.25M | 96.6× | — | — | — | $644.21K | — | AI pending |
| FXNCFirst National Corp | $281.09M | 13.0× | $90.26M | +31.1% | $17.7M | $166.15M | $1.84M | AI pending |
| REFIChicago Atlantic Real Estate Finance, Inc. | $280.94M | 8.0× | $48.86M | — | $32.29M | $13.35M | $49.45M | AI pending |
| PAIIPyrophyte Acquisition Corp. II | $280.58M | 46.5× | — | — | — | $1.14K | — | AI pending |
| PDYNPalladyne AI Corp. | $280.24M | — | $5.25M | -32.6% | $10.04M | $33.77M | $10.56M | AI pending |
| TRDAEntrada Therapeutics, Inc. | $278.01M | — | $25.42M | -87.9% | -$143.75M | $99.28M | $48.54M | AI pending |
| MFINMedallion Financial Corp | $277.82M | 9.1× | $254.89M | +19.2% | $43.04M | $172.58M | $2.65B | AI pending |
| ISNRSnow Rothschild Acquisition Corp. | $277.7M | — | — | — | — | $1.24M | — | AI pending |
| NHIVNewHold Investment Corp IV | $277.49M | — | — | — | — | $1.33M | — | AI pending |
| RWAYRunway Growth Finance Corp. | $277.44M | 61.3× | $137.33M | -5.0% | $34.05M | $10.83M | $678.95M | AI pending |
| WNEBWestern New England Bancorp, Inc. | $277.43M | 16.6× | $82.61M | +13.6% | $15.27M | $37.67M | $62.55M | AI pending |
| TTGTTechTarget, Inc. | $277.4M | — | $486.79M | +70.9% | -$1.01B | $45.82M | $11.57M | AI pending |
| CNCKCoincheck Group N.V. | $277.29M | — | ¥383.33B | +71.1% | -¥14.35B | ¥10.65B | ¥500M | AI pending |
| ALXOAlx Oncology Holdings Inc | $277.25M | — | $0 | — | -$123.48M | $22.69M | $11.04M | AI pending |
| JAKKJakks Pacific Inc | $276.63M | 17.4× | $570.67M | -17.4% | $9.87M | $59.51M | $46.62M | AI pending |
| XSLLXsolla SPAC 1 | $276.52M | 103.1× | — | — | — | $1.75M | — | AI pending |
| RNACCartesian Therapeutics, Inc. | $275.78M | — | $400K | -99.0% | -$130.3M | $147.61M | $63.85M | AI pending |